Monica Prokoczki
Vice President of Finance and Investor Relations
Replay available
LifeStance Health Group, Inc. (NASDAQ: LFST) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Vice President of Finance and Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Goldman Sachs
Analyst, William Blair
Analyst, Conaccord Genuity
Good day, everyone, and thank you for standing by. My name is Orgy, and I will be your conference operator today. At this time, I would like to welcome everyone to LifeStance Health first quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask questions during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Monica Prokoczki. Please go ahead. Thank you, operator. Good morning, everyone, and welcome to LifeStance Health's first quarter 2025 earnings conference call. I'm Monica Prokoczki, Vice President of Finance and Investor Relations. Joining me today are Dave Borden, Chief Executive Officer, and Ryan McGrory, Chief Financial Officer. In addition, Ken Burdick, our Executive Chairman, is also with us. We issued the earnings release and presentation before the market opened this morning. Both are available on the Investor Relations section of our website, investor.lifesense.com. In addition, a replay of this conference call will be available following the call. Before turning the call over to management for their prepared remarks, please direct your attention to the disclaimers about forward-looking statements included in the earnings press release and SEC filings. Today's remarks contain forward-looking statements, including statements about our financial performance outlook, business model, and strategy. Those statements involve risks, uncertainties, and other factors, as noted in our periodic filings with the SEC, that could cause actual results to differ materially. In addition...